RÉSUMÉ
OBJECTIVES: To determine the infection and nonunion rates for open tibia fracture treatment over the past 4 decades since the introduction of the Gustilo-Anderson (GA) open fracture classification. DATA SOURCES: PubMed, Scopus, CINAHL, and Cochrane databases were reviewed using the PRISMA checklist for articles between 1977 and September 2018. STUDY SELECTION: One hundred sixty-one articles meeting the following inclusion criteria: English language, published between 1977 and 2018, reported infection rates, reported nonunion rates, and fractures classified by the GA open fracture criteria were selected. DATA EXTRACTION: All articles were thoroughly evaluated to extract infection and nonunion data for open tibia fractures. DATA SYNTHESIS: Due to variability in the data reviewed, statistical evaluation could not be reliably done. RESULTS: 11,326 open tibia fractures were reported with 17% type I, 25.2% type II, 25.3% type IIIA, and 32.5% type IIIB/C. The average infection rate over 4 decades was 18.3%, with 24.3% superficial, 11.2% deep, and 14.7% pin tract. The infection rate by decade was 14% for 1977-1986, 16.2% for 1987-1996, 20.5% for 1997%-2006%, and 18.1% from 2007 to 2017. The overall nonunion rate was 14.1%. The nonunion rate was 13% for 1977-1986, 17% for 1987-1996, 12.8% for 1997%-2006%, and 12.3% for 2007-2017. CONCLUSIONS: This in-depth summary has demonstrated that the percentage rate for infections and nonunion has remained similar over the past 40 years. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Sujet(s)
Fractures ouvertes , Fractures du tibia , Humains , Tibia , Fractures ouvertes/épidémiologie , Fractures ouvertes/chirurgie , Études rétrospectives , Fractures du tibia/épidémiologie , Fractures du tibia/chirurgie , Résultat thérapeutiqueSujet(s)
Sténose aortique/imagerie diagnostique , Valve aortique/imagerie diagnostique , Échocardiographie-doppler , Échocardiographie de stress/méthodes , Épreuve d'effort , Sujet âgé , Valve aortique/physiopathologie , Sténose aortique/physiopathologie , Maladies asymptomatiques , Femelle , Hémodynamique , Humains , Valeur prédictive des tests , Indice de gravité de la maladieSujet(s)
Sténose aortique/imagerie diagnostique , Échocardiographie de stress/méthodes , Hypertrophie ventriculaire gauche/imagerie diagnostique , Indice de gravité de la maladie , Sujet âgé de 80 ans ou plus , Sténose aortique/complications , Femelle , Humains , Hypertrophie ventriculaire gauche/complicationsSujet(s)
Choriocarcinome/diagnostic , Cytodiagnostic , Tumeurs de l'estomac/diagnostic , Testicule/anatomopathologie , Choriocarcinome/anatomopathologie , Humains , Immunohistochimie , Mâle , Tumeurs embryonnaires et germinales , Test de Papanicolaou , Tumeurs de l'estomac/anatomopathologie , Tumeurs de l'estomac/secondaire , Tumeurs du testiculeRÉSUMÉ
The purpose of this case report is to point out the diagnostic value of cytologic smears in patients presenting with anorectal complaints, such as bleeding, pain or discomfort, which may suggest a neoplastic lesion. We present a case of a 64-year-old man with a 3 months' history of anal bleeding and pain during defecation. He was diagnosed as having hemorrhoids and a hemorrhoidectomy was performed. The patient developed an anal stricture postoperatively that required operative dilation. He continued to complain about anorectal pain for 2 months and a subsequent rectoscopy revealed the presence of tumor 5 to 7 cm above the dentate line. The tumor was resected laparoscopically and was reported as an adenocarcinoma. Rectal bleeding recurred 18 months postoperatively and a smear was procured from the anorectal mucosal surface for cytologic evaluation. A definitive diagnosis of adenocarcinoma was rendered based on cytologic and histologic examination of the material. To the best of our knowledge, this is the first case report of anorectal adenocarcinoma diagnosed by cytologic smear in the English literature.
RÉSUMÉ
OBJECTIVE: To study the DNA ploidy pattern of uterine cervical squamous intraepithelial lesions (SILs) and its diagnostic and prognostic significance. METHODS: The study included 31 cases of SIL: 11 low-grade (LSIL) and 20 high-grade (HSIL). Feulgen-pararosaniline staining was performed on previously Papanicolaou-stained smears and a DNA image cytometric study was performed. An internal reference was used to calibrate the samples. RESULTS: All 31 cases of SIL, either LSIL or HSIL, were non-diploid. Of the 11 cases of LSIL, four were tetraploid and seven were aneuploid, whereas, of the 20 cases of HSIL, four were tetraploid and 16 were aneuploid. Stemline aneuploidy was not a significant discriminator between LSIL and HSIL (P=0.32). Based on single-cell analysis, HSIL cases had significantly higher DNA content than LSIL cases (P<0.01). When a mean of 30% or more was used for the 6c-exceeding event (6cEE) value, the sensitivity and specificity to indicate HSIL were 83% and 64%, respectively, with a positive predictive value (PPV) of 81% and negative predictive value (NPV) of 65%. All HSIL cases were cervical intraepithelial neoplasia grade 2 or worse (CIN2+) on biopsy. In addition, cases which showed recurrence had more DNA content by single-cell analysis than those with an indolent clinical behaviour: P=0.04 and P=0.03 for LSIL and HSIL, respectively. CONCLUSIONS: Image cytometric DNA analysis is a useful technique for diagnostic and prognostic purposes in uterine cervical SIL when appropriate 'c' values are used in single-cell analysis. We propose that a >6c DNA content of 30% is useful as a cut-off level for predicting cases with CIN2+ in DNA image cytometry of cervical smears.
Sujet(s)
ADN , Cytométrie en images/méthodes , Dysplasie du col utérin/diagnostic , Tumeurs du col de l'utérus/diagnostic , Adulte , Biopsie , Cytodiagnostic , ADN/isolement et purification , Femelle , Études de suivi , Humains , Adulte d'âge moyen , Test de Papanicolaou , Ploïdies , Grossesse , Analyse sur cellule unique , Tumeurs du col de l'utérus/épidémiologie , Tumeurs du col de l'utérus/anatomopathologie , Frottis vaginaux/méthodes , Dysplasie du col utérin/épidémiologie , Dysplasie du col utérin/anatomopathologieRÉSUMÉ
OBJECTIVE: Ten patients with recurrent ovarian cancer received a combined treatment of optimal tumor debulking, adenovirus-mediated herpes simplex virus thymidine kinase gene therapy (GT), and systemic application of acyclovir or valacyclovir and topotecan. Biopsies were taken at the time of secondary debulking about 1 month after the application of GT and chemotherapy and were analyzed for expression of coxsackie-adenovirus receptor (CAR) and integrins alphavbeta3 and alphavbeta5 with respect to treatment response. METHODS: Treatment modalities and study design have been described recently. Immunohistochemistry was used to visualize expression of CAR and integrins alphavbeta3 and alphavbeta5 in tumor samples taken before and after application of GT. RESULTS: Before GT six of ten patients presented with CAR-positive and four with CAR-negative tumors. After GT all tumors showed CAR expression. Integrin alphavbeta3 was found in all tumors before and after GT. Expression of integrin alphavbeta5 was seen in eight of ten tumor samples before GT and in all samples after GT. CONCLUSION: Despite the importance of CAR and integrin expression for successful adenovirus internalization, other cell surface receptors might be involved in this process. It is too early to decide whether expressions of CAR and integrin alphavbeta3/alphavbeta5 on tumor cells are appropriate additional inclusion criteria for the enrollment of patients in GT trials. Further research is necessary to evaluate the effect of GT plus chemotherapy on CAR and integrin expression.
Sujet(s)
Enterovirus/génétique , Thérapie génétique/effets indésirables , Intégrines/génétique , Tumeurs de l'ovaire/thérapie , Récepteur vitronectine/génétique , Thymidine kinase/génétique , Adulte , Sujet âgé , Relation dose-effet des médicaments , Femelle , Thérapie génétique/méthodes , Vecteurs génétiques , Humains , Adulte d'âge moyen , Stadification tumorale , Tumeurs de l'ovaire/anatomopathologie , Tumeurs de l'ovaire/chirurgie , Récidive , Chirurgie de second regardRÉSUMÉ
Herpes simplex virus (HSV) thymidine kinase (tk) gene incorporated into adenovirus was delivered intraperitoneally (ip) followed by an antiherpetic prodrug and topotecan in patients with recurrent epithelial ovarian cancer. Tissue response was evaluated. Ten patients underwent secondary debulking with subsequent delivery of ADV-HSV-tk therapy. Two patients each were treated at dose level 1 (2 x 10(10) vector particles = VP), 2 (2 x 10(11) VP), and 3 (2 x 10(12) VP); four patients were treated at dose level 4 (2 x 10(13) VP). Five patients underwent second-look surgery about one month after gene therapy (GT). Treatment response, presence of vector DNA, protein expression of steroid hormone receptors, p53, c-erbB2 and Ki67 protein were analyzed. At second-look, two out of five patients were tumor-free and none of their peritoneal biopsies showed vector DNA. After GT, the vital tumor mass was smaller, desmoplastic reaction had increased, and tumors were less differentiated with an increase of Ki67 expression. There was no change in expression of hormone receptors, p53, or c-erbB2. ADV-HSV-tk GT appears to eliminate cells with higher differentiation first and might induce fibrosis. Dedifferentiation might render residual cells more sensitive to chemotherapy secondary to their subsequent higher mitotic activity.
Sujet(s)
Adénovirus humains/génétique , Thérapie génétique/méthodes , Tumeurs de l'ovaire/thérapie , Simplexvirus/enzymologie , Thymidine kinase/génétique , Antinéoplasiques/usage thérapeutique , Antiviraux/usage thérapeutique , Marqueurs biologiques tumoraux/métabolisme , Carcinome endométrioïde/métabolisme , Carcinome endométrioïde/anatomopathologie , Carcinome endométrioïde/thérapie , Association thérapeutique , Cystadénocarcinome papillaire/métabolisme , Cystadénocarcinome papillaire/anatomopathologie , Cystadénocarcinome papillaire/thérapie , Amorces ADN/composition chimique , ADN viral/analyse , Femelle , Fibrose , Humains , Techniques immunoenzymatiques , Antigène KI-67/métabolisme , Tumeurs de l'ovaire/métabolisme , Tumeurs de l'ovaire/anatomopathologie , Réaction de polymérisation en chaîne , Récepteur ErbB-2/métabolisme , Chirurgie de second regard , Thymidine kinase/métabolisme , Topotécane/usage thérapeutique , Protéine p53 suppresseur de tumeur/métabolismeRÉSUMÉ
OBJECTIVE: To illustrate some of the uncommon cytologic findings of gynecomastia, such as apocrine metaplasia, cellular atypia and foamy macrophages, that can be misinterpreted as evidence of malignancy. STUDY DESIGN: The clinical data and fine needle aspiration (FNA) cytologic material from 100 men with the diagnosis of gynecomastia were retrospectively reviewed. The excisional biopsy slides were available for 16 cases. For comparison, FNA smears from five men with breast lesions other than gynecomastia were studied. RESULTS: The patients ranged in age from 23 to 91 years. Cytologic findings were as follows: cohesive sheets of cells containing 20-1,000 cells (98%); scattered, single, bipolar cells (78%); spindle cells (68%); ductal epithelial atypia (26%); apocrine metaplasia (8%); and foamy histiocytes (12%). In nine cases the atypia was marked, and in two of them the possibility of malignancy could not be ruled out. Surgical follow-up on 16 patients, including the cases with marked atypia, showed gynecomastia. In one case, gynecomastia was associated with intraductal papilloma. No correlation between the underlying etiology and atypical cytologic features of gynecomastia was identified. CONCLUSION: Apocrine metaplasia and epithelial atypia are common findings in gynecomastia. Attention to the cell patterns, the presence of sheets of ductal cells and absence of atypical single cells will point to the correct diagnosis.
Sujet(s)
Ponction-biopsie à l'aiguille/méthodes , Gynécomastie/anatomopathologie , Adulte , Répartition par âge , Sujet âgé , Sujet âgé de 80 ans ou plus , Glandes apocrines/anatomopathologie , Tumeurs du sein/complications , Tumeurs du sein/anatomopathologie , Gynécomastie/complications , Humains , Mâle , Métaplasie/anatomopathologie , Adulte d'âge moyen , Papillome intracanalaire/complications , Papillome intracanalaire/anatomopathologie , Études rétrospectivesRÉSUMÉ
OBJECTIVE: To use MIB-1 antibody to assess proliferative activity in fine needle aspiration (FNA) samples of invasive breast carcinoma and compare these results to multiple other measures of proliferative activity. STUDY DESIGN: FNA slides from 62 patients with invasive breast carcinoma were subjected to staining with MIB-1. Quantitative MIB-1 values were compared to image analytic proliferative fractions (IPF) obtained from the same FNAs. MIB-1 values were also compared to flow cytometric S-phase fractions (SPF) and S + G2/M-phase fractions (FPF) and to histologic assessment of mitotic count (MC) in resected tumors. RESULTS: MIB-1 values, IPF, SPF, FPF and MC were suitable for evaluation in 55, 53, 50, 50 and 56 cases, respectively. MIB-1 values showed good correlation with IPF in FNAs (correlation coefficient = .57, P <.00001). MIB-1 values also showed correlation with SPF (correlation coefficient =.447, P = .003), FPF (correlation coefficient = .325, P = .023) and MC (correlation coefficient = .402, P = .01) in resected tumors. CONCLUSION: This study supports the use of MIB-1 values obtained from FNA samples for assessment of proliferative activity in invasive breast carcinoma, based on correlation of these values with multiple other parameters of proliferative activity. Assessment of these values can play a role in predicting prognosis and in selecting patients with invasive carcinoma of the breast for preoperative or adjuvant chemotherapy.
Sujet(s)
Adénocarcinome/anatomopathologie , Tumeurs du sein/anatomopathologie , Protéines nucléaires/métabolisme , Adénocarcinome/composition chimique , Adénocarcinome/génétique , Adénocarcinome/métabolisme , Antigènes nucléaires , Ponction-biopsie à l'aiguille , Tumeurs du sein/composition chimique , Tumeurs du sein/génétique , Tumeurs du sein/métabolisme , Cycle cellulaire , Division cellulaire , ADN tumoral/analyse , Femelle , Cytométrie en flux , Humains , Cytométrie en images , Immunohistochimie , Antigène KI-67 , Invasion tumorale/anatomopathologie , Protéines nucléaires/analyse , Ploïdies , Reproductibilité des résultatsRÉSUMÉ
OBJECTIVE: Patients with recurrent ovarian cancer were treated intraperitoneally (ip) with a replication-deficient recombinant adenovirus (ADV) containing the herpes simplex virus thymidine kinase gene. Vector delivery was followed by intravenous administration of an antiherpetic prodrug and a topoisomerase I inhibitor. METHODS: Ten patients with stage IIIc epithelial ovarian cancer underwent secondary debulking to < or =0.5 cm residual tumor. Patients with normal ip flow received delivery of ip ADV. Two patients each were treated on dose level 1 (2 x 10(10) vector particles), dose level 2 (2 x 10(11)), and dose level 3 (2 x 10(12)); four patients were on dose level 4 (2 x 10(13)). Acyclovir and topotecan were started 24 h after vector delivery. Five patients underwent second-look surgery about 4 weeks after application of gene therapy (GT). RESULTS: At the time of the second-look surgery, two out of five patients were free of tumor. Four weeks after GT none of the peritoneal biopsies showed residual vector DNA. Patients pretreated with an average of three different chemotherapeutic drugs and two different chemotherapy regimens had a median overall survival (OS) of 18.5 months. Three patients are still alive 30, 30, and 31 months after GT. CONCLUSION: With the combination of secondary optimal debulking, GT, and topotecan, median OS was about one-third longer than in previously reported second-and third-line trials. Survival was comparable to that of patients of other studies with secondary cytoreductive surgery in combination with chemotherapy.
Sujet(s)
Antinéoplasiques/usage thérapeutique , Antienzymes/usage thérapeutique , Thérapie génétique/méthodes , Tumeurs de l'ovaire/thérapie , Thymidine kinase/génétique , Topotécane/usage thérapeutique , Aciclovir/pharmacocinétique , Aciclovir/usage thérapeutique , Adenoviridae/enzymologie , Adenoviridae/génétique , Adulte , Sujet âgé , Antinéoplasiques/pharmacocinétique , Antiviraux/pharmacocinétique , Antiviraux/usage thérapeutique , Association thérapeutique , Antienzymes/pharmacocinétique , Femelle , Humains , Adulte d'âge moyen , Tumeurs de l'ovaire/traitement médicamenteux , Tumeurs de l'ovaire/génétique , Tumeurs de l'ovaire/chirurgie , Chirurgie de second regard , Thymidine kinase/métabolisme , Topotécane/pharmacocinétiqueRÉSUMÉ
BACKGROUND: Paragangliomas are uncommon tumors, only 10% of which are malignant, as evidenced by metastatic disease. It is rare for paraganglioma to present with symptomatic osseous metastases. CASE: A retroperitoneal paraganglioma presented in a 52-year-old man as painful metastases in the rib and vertebrae. Fine needle aspiration (FNA) of a lumbar vertebral lesion showed cells arranged singly and in loose clusters with fragile, vacuolated or finely granular cytoplasm, marked anisonucleosis and mitoses. Rare zellballen-type structures and intranuclear inclusions were present. Immunohistochemical studies of a subsequent FNA core biopsy of the retroperitoneal mass showed strong immunoreactivity with chromogranin and negative staining for keratin; that was helpful in differentiating this tumor from others in the differential diagnosis. CONCLUSION: The cytologic diagnosis of paraganglioma is difficult as these tumors exhibit a plethora of features that overlap those of many other neoplasms. The diagnosis can be confirmed with appropriate immunohistochemical studies of corresponding core biopsies.
Sujet(s)
Ponction-biopsie à l'aiguille , Tumeurs osseuses/anatomopathologie , Tumeurs osseuses/secondaire , Vertèbres lombales , Paragangliome/anatomopathologie , Paragangliome/secondaire , Tumeurs du rétropéritoine/anatomopathologie , Marqueurs biologiques tumoraux/métabolisme , Tumeurs osseuses/diagnostic , Tumeurs osseuses/métabolisme , Carcinomes/diagnostic , Chromogranine/métabolisme , Diagnostic différentiel , Humains , Vertèbres lombales/imagerie diagnostique , Mâle , Mélanome/diagnostic , Adulte d'âge moyen , Paragangliome/diagnostic , Paragangliome/métabolisme , Tumeurs du rétropéritoine/diagnostic , Tumeurs du rétropéritoine/métabolisme , Sarcomes/diagnostic , TomodensitométrieRÉSUMÉ
BACKGROUND: The diagnosis of atypical squamous cells of undetermined significance (ASCUS) remains an enigma for the treating physician, because it encompasses both benign, reactive, as well as preneoplastic and possibly neoplastic conditions. To address this problem, The Bethesda System recommends qualifying the ASCUS diagnosis. This study analyzes the difference in the follow-up results between the various groups of patients with an ASCUS diagnosis as outlined by the Criteria Committee: favor premalignant (ASCUS-P), favor reactive (ASCUS-R), and unqualified (ASCUS-C). The outcome, based on follow-up biopsies and/or cytologies, for both the conventional Papanicolaou smear (CS) and liquid-based (LB) methodologies is compared. METHODS: The CS and LB biopsies and/or cytologies included 590 patients and 137 patients, respectively, who had an initial diagnosis of ASCUS. The final outcome after subsequent biopsy and cytology within a 1-year period for each methodology was tabulated. Furthermore, the addition of qualifiers for each diagnosis was tabulated for both cytology and biopsy follow-up and compared between CS and LB technologies. RESULTS: For CS, 29 patients (8.6%) were found to have squamous intraepithelial lesions (SIL) on subsequent cytologic smears, and 176 patients (63.7%) had SIL on biopsy follow-up. For LB, these numbers were 17 patients (19.1%) and 56 patients (65.1%), respectively. Regardless of the qualification used in the initial CS biopsy or cytology, over 90% of the subsequent smears resulted in a benign diagnosis. Biopsy outcomes after CS diagnoses of ASCUS-P, ASCUS-R, and ASCUS-C showed SIL in 80%, 53%, and 66% of patients, respectively. For LB diagnoses, subsequent smears detected SIL in 33% of patients with a diagnosis of ASCUS-P, 22% of patients with a diagnosis of ASCUS-R, and 12% of patients with a diagnosis of ASCUS-C. Biopsy outcomes after LB diagnoses of ASCUS-P, ASCUS-R, and ASCUS-C showed SIL in 68%, 64%, and 66% of patients, respectively. CONCLUSIONS: There appears to be no statistically valid benefit from a clinical point of view in qualifying an ASCUS interpretation by either CS or LB, except for CS evaluation of patients with a diagnosis of ASCUS-P.
Sujet(s)
Col de l'utérus/anatomopathologie , Test de Papanicolaou , Tumeurs du col de l'utérus/diagnostic , Frottis vaginaux/méthodes , Biopsie , Femelle , HumainsRÉSUMÉ
CONTEXT: Fine-needle aspiration has become an accepted and cost-effective procedure for rapid diagnosis of thyroid lesions. The routine use of fine-needle aspiration has reduced the rate of unnecessary surgery for thyroid nodules. OBJECTIVES: To determine the accuracy of fine-needle aspiration biopsy diagnosis and to discuss the possible pitfalls. Design, Setting, and Participants.-Reports of 6226 fine-needle aspiration biopsies of the thyroid performed during a period of 16 years (1982-1998) were reviewed. Computerized reports of the fine-needle aspiration biopsies were sent to the physicians who performed the procedures, and clinical follow-up information regarding the patients was requested. Twenty-four clinicians participated in the study. Histologic diagnoses were available for 354 cases. The cytopathologic diagnoses were correlated with the histologic findings or clinical outcomes. RESULTS: The cytologic diagnoses were as follows: 210 (3.4%) malignant, 450 (7.2%) suspicious, 3731 (60%) benign, and 1845 (29.5%) unsatisfactory. Most of the cases with negative or unsatisfactory aspirates were followed clinically or by repeat fine-needle aspiration. We identified 11 false-negative and 7 false-positive diagnoses. For aspirates considered sufficient for diagnosis, the sensitivity and specificity levels were 93% and 96%, respectively. CONCLUSIONS: Fine-needle aspiration of the thyroid gland is highly accurate and has a low rate of false-negative and false-positive diagnoses. The major diagnostic problems are caused by diagnosis using a marginally adequate specimen, diagnosis of malignancy based on just 1 or 2 atypical cytologic features, or overlapping cytologic features of follicular neoplasm with those of follicular variant of papillary carcinoma.
Sujet(s)
Ponction-biopsie à l'aiguille , Nodule thyroïdien/diagnostic , Carcinome papillaire/diagnostic , Carcinome papillaire folliculaire/diagnostic , Diagnostic différentiel , Faux négatifs , Faux positifs , Études de suivi , Valeur prédictive des tests , Reproductibilité des résultatsRÉSUMÉ
This study focused on 19 patients with renal lymphoma (RL) from whom 20 initial (1 patient with fine-needle aspiration [FNA] specimens of masses in both kidneys) and 1 repeated FNA specimen were obtained. Of the 19 patients, 10 had secondary RL, 8 primary RL, and 1 transplant RL. The FNA samples were studied by smears (all cases), tissues (11), phenotyping by immunostaining (13) or flow cytometry (4), and gene rearrangement (3). The final diagnoses included 1 T-cell lymphoma and 18 B-cell lymphomas. Of the 20 original specimens, 14 were reported as positive for lymphoma, 3 suggestive of lymphoma, 1 positive for transitional cell carcinoma, and 2 unsatisfactory. The follow-up specimen showed reactive changes. Tissue correlation, available in 11 cases, confirmed a positive cytodiagnosis (7), provided a final diagnosis in the cytologically inconclusive cases (3), or revised the misdiagnosis of transitional cell carcinoma from smears (1). The phenotyping elucidated the B vs T lineage of the lymphoma in all tested cases, confirmed the positive cytodiagnosis in 10 cases, confirmed the reactive cytodiagnosis in 1 case, and helped achieve a conclusive diagnosis in 2 cases suggestive of lymphoma. Gene rearrangement studies showed light chain restriction in the 2 tested cases. FNA has an essential role in treatment planning for RL. Although FNA usually is diagnostically conclusive, a high index of suspicion and awareness of atypical or misleading cytomorphologic features are important for a correct interpretation, especially for primary RL. Ancillary testing is essential for the diagnosis in problematic cases and lays the foundation for the differential diagnosis.
Sujet(s)
Ponction-biopsie à l'aiguille , Tumeurs du rein/anatomopathologie , Lymphome B/anatomopathologie , Lymphome T/anatomopathologie , Adulte , Sujet âgé , Enfant , Femelle , Réarrangement des gènes , Humains , Tumeurs du rein/imagerie diagnostique , Tumeurs du rein/génétique , Lymphome B/imagerie diagnostique , Lymphome B/génétique , Lymphome T/imagerie diagnostique , Lymphome T/génétique , Mâle , Adulte d'âge moyen , Phénotype , TomodensitométrieRÉSUMÉ
BACKGROUND: Osteomyelitis due to Cryptococcus neoformans typically exhibits lytic lesions on radiographs. Extensive periosteal reaction is an uncommon feature. CASE: A 68-year-old man presented with pain and swelling in the left elbow. Radiologic studies exhibited a lytic humeral lesion with extensive periosteal reaction, interpreted as a malignant neoplasm. Fine needle aspiration biopsy (FNA) revealed abundant cryptococcal organisms. CONCLUSION: Cryptococcus is an uncommon cause of lytic osseous lesions that may mimic malignant neoplasms. Extensive periosteal reaction may support a radiologic diagnosis of primary osseous malignancy in rare cases. FNA with examination of Diff-Quik-stained slides may be employed for distinguishing cryptococcal osteomyelitis from malignant tumors and for prompt identification of the organisms.
Sujet(s)
Tumeurs osseuses/anatomopathologie , Cryptococcose/anatomopathologie , Ostéomyélite/anatomopathologie , Sujet âgé , Ponction-biopsie à l'aiguille , Tumeurs osseuses/diagnostic , Tumeurs osseuses/imagerie diagnostique , Cryptococcose/diagnostic , Diagnostic différentiel , Humains , Mâle , Ostéomyélite/diagnostic , Ostéomyélite/imagerie diagnostique , RadiographieRÉSUMÉ
This study was undertaken to assess the role of fine-needle aspiration biopsy in the evaluation of palpable peripheral lymphadenopathy in pediatric and adolescent patients. A 15-year experience in aspiration of patients younger than age 21 was reviewed. These cases were taken from four large university hospitals and clinics. Data included clinical information, anatomic site, cytologic diagnosis, and any follow-up surgical excision at these institutions. From a total of 1,302 lymph node fine-needle aspirates, a subset of 106 aspirates from patients 21 years or younger was selected. This group formed the basis for this study, and these aspirates were obtained from 103 patients. Most of these aspirates (88.7%) were from the head and neck; 11 were from sites other than head and neck; and the site was not stated in one case. One hundred and one of the aspirates produced adequate samples, and only five (4.72%) were unsatisfactory. Of the 106 fine-needle aspirates, 88 (83.0%) were diagnosed as negative for malignancy, five (4.7%) were inconclusive, and three (2.8%) were interpreted as suspicious but not diagnostic of malignancy. Five cases (4.7%) were diagnosed as positive for malignancy, including two cases of metastatic papillary carcinoma of the thyroid, two cases of Hodgkin's disease, and a single case of high-grade non-Hodgkin's lymphoma. No false-positive or false-negative diagnoses occurred, excluding the aspirates classified as inconclusive or suspicious but not diagnostic of malignancy (six cases). Results of aspirates from near adolescent and adolescent patients (ages 11-21 years) were compared with those of younger pediatric patients (age < 10 years). Eighty-one (76%) of the 106 aspirates were obtained from the older group. The percentage of unsatisfactory specimens was smaller and the percentage of inconclusive or suspicious or malignant diagnoses was greater in the older group. Fine-needle aspiration biopsy is reliable in the evaluation of palpable peripheral lymphadenopathy. As most fine-needle aspirates in children and adolescents proved to indicate benign reactive conditions that failed to respond to antibiotics rather than proving to be malignant tumors, we advocate a larger role for the fine-needle aspiration biopsy technique in the evaluation of peripheral lymphadenopathy in this age group. Its early use can direct further testing, saving time, expense, and morbidity for the patient and reducing anxiety for the parents.
Sujet(s)
Ponction-biopsie à l'aiguille/méthodes , Maladies lymphatiques/diagnostic , Maladies lymphatiques/anatomopathologie , Maladies lymphatiques/thérapie , Adolescent , Adulte , Facteurs âges , Enfant , Enfant d'âge préscolaire , Femelle , Tumeurs de la tête et du cou/diagnostic , Tumeurs de la tête et du cou/anatomopathologie , Tumeurs de la tête et du cou/thérapie , Maladie de Hodgkin/diagnostic , Maladie de Hodgkin/anatomopathologie , Maladie de Hodgkin/thérapie , Humains , Nourrisson , Nouveau-né , Macrophages/métabolisme , Mâle , Granulocytes neutrophiles/métabolisme , Tumeurs de la thyroïde/diagnostic , Tumeurs de la thyroïde/anatomopathologie , Tumeurs de la thyroïde/thérapieRÉSUMÉ
INTRODUCTION: Patients with recurrent ovarian cancer were treated with a replication-deficient recombinant adenovirus containing the herpes simplex virus thymidine kinase gene administered intraperitoneally (i.p.) followed by administration of an anti-herpetic prodrug and topotecan. MATERIALS AND METHODS: A total of 10 patients with stage IIIc epithelial ovarian cancer underwent secondary debulking to < or =0.5 cm residual tumor. Patients with normal i.p. flow received i.p. delivery of adenovirus. Two patients each were treated on dose level 1 (2 x 10(10) vector particles (VP)), dose level 2 (2 x 10(11) VP), and dose level 3 (2 x 10(12) VP); four patients were treated on dose level 4 (2 x 10(13) VP). Acyclovir and topotecan were started 24 hours after vector delivery. RESULTS: No patient treated at any dose level incurred unanticipated toxic effects, and all side effects resolved. The most common adverse event was myelosuppression: grade 3 or 4 thrombocytopenia with grade 2-4 anemia in three patients and grade 3 or 4 neutropenia in eight patients. Three patients developed thrombocytosis and three patients had a mild elevation of serum glutamic pyruvic transaminase/alanine aminotransferase. Temperature elevations that were not associated with detectable infection occurred in two patients. DISCUSSION: I.p. delivery of adenoviral vector with concomitant topotecan chemotherapy was well tolerated without significant lasting toxicities. Side effects were independent of the dose of adenoviral vector.
Sujet(s)
Antienzymes/usage thérapeutique , Thérapie génétique/méthodes , Récidive tumorale locale/thérapie , Tumeurs de l'ovaire/thérapie , Thymidine kinase/génétique , Topotécane/usage thérapeutique , Aciclovir/administration et posologie , Aciclovir/usage thérapeutique , Adénocarcinome/thérapie , Adénocarcinome à cellules claires/thérapie , Adenoviridae/génétique , Adulte , Sujet âgé , Antiviraux/administration et posologie , Antiviraux/usage thérapeutique , Association thérapeutique , Cystadénocarcinome papillaire/thérapie , ADN/analyse , Antienzymes/administration et posologie , Femelle , Études de suivi , Techniques de transfert de gènes , Vecteurs génétiques , Humains , Injections péritoneales , Adulte d'âge moyen , Réaction de polymérisation en chaîne , Topotécane/administration et posologieRÉSUMÉ
Morbidity due to schistosomiasis was evaluated in a subpopulation of 14,000 of the randomized sample in the Epidemiology 1, 2, 3 Project. It was measured by using a standardized questionnaire for obtaining medical history and symptoms and by performing standardized physical and ultrasound examinations. Reported herein are descriptions of the methods and training and quality control efforts made to insure that the morbidity data was reliable and consistent when collected by 7 different teams in 9 different governorates.
Sujet(s)
Examen physique/normes , Bilharziose urinaire/épidémiologie , Schistosomiase à Schistosoma mansoni/épidémiologie , Échographie/normes , Égypte/épidémiologie , Humains , Recueil de l'anamnèse/normes , Dossiers médicaux/normes , Morbidité , Contrôle de qualité , Bilharziose urinaire/diagnostic , Bilharziose urinaire/imagerie diagnostique , Schistosomiase à Schistosoma mansoni/diagnostic , Schistosomiase à Schistosoma mansoni/imagerie diagnostique , Enquêtes et questionnaires , Échographie/instrumentationRÉSUMÉ
Health questionnaires and parasitologic examinations of urine and stool were performed upon a stratified random sample of 10,899 individuals from 1,537 households in 27 rural communities in Menofia Governorate in Egypt in 1992 to investigate the prevalence of, risk factors for, and changing pattern of infection with Schistosoma sp. in the governorate. A subset, every fifth household, or 1,480 subjects, had physical and ultrasound examinations to investigate prevalence of and risk factors for morbidity. The prevalence of S. mansoni ranged from 0.3% to 72.9% and averaged 28.5%. The geometric mean egg count was 81.3 eggs/gram of stool. Age-stratified prevalence and intensity of infection was 30-40% and 60-80 eggs/gram of stool from the age of 10 onward; males had higher infection rates and ova counts than females in all age groups > 10 years old. Schistosoma haematobium was rare, being consequential in only 1 community. Risk factors for S. mansoni infection were male gender; age > 10 years; living in smaller communities; exposures to canal water; history of or treatment for schistosomiasis or blood in the stool; detection of splenomegaly by either physical or ultrasound; and ultrasound-detected periportal fibrosis (PPF). The more severe grades of PPF were rarely (21 of 1,450 examinations) detected. Risk factors for morbidity, i.e., ultrasound-detected PPF, were similar to those for infection. Schistosoma mansoni has almost totally replaced S. haematobium in Menofia. The prevalence of S. mansoni in rural communities remains high and average intensities of infection are moderate. The association of morbidity with schistosomal infection was variable and is obviously markedly influenced by both the frequent use of antischistosomal chemotherapy in communities in Menofia and by the prevalence of complications from chronic viral hepatitis in the population: hepatomegaly did not correlate with infection; PPF and splenomegaly, however, were related to S. mansoni infection in both individuals and communities.